Benefits of Participation
- You are helping to provide the information needed to learn about the variations of MS in a very large group of patients and to monitor the progression of the disease
- You help us monitor the effects of various treatments. Your information may be providing ideas for future research
- You will be receiving the printed version of the MSQR free of charge
- You will be informed of recent studies and their results
- You will be notified of clinical trials in which you may be eligible to participate
The current newsletter is at http://www.narcoms.org/files/NARCOMS_Newsletter_1_Oct0509.pdf, which includes some information on Vitamin D:
The MS Association had this to say about Vitamin D3:
- An inverse relationship appears to exist between vitamin D3 status and the probability of developing MS. Vitamin D3 supplementation may be a possible therapy in MS.
- A Phase I/II trial of high-dose oral vitamin D3 with calcium trial showed that high-dose Vitamin D3 - 10,000 IU/day or higher - is safe and tolerable, with some evidence of clinical improvement. More data are needed.
No comments:
Post a Comment